AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $59,000 | +883.3% | 1,244 | +551.3% | 0.00% | – |
| Q3 2019 | $6,000 | -84.6% | 191 | -75.9% | 0.00% | – |
| Q2 2019 | $39,000 | -51.2% | 791 | -33.8% | 0.00% | -100.0% |
| Q1 2019 | $80,000 | +45.5% | 1,195 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $55,000 | -20.3% | 1,195 | +33.1% | 0.00% | 0.0% |
| Q3 2018 | $69,000 | -8.0% | 898 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $75,000 | +2.7% | 892 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $73,000 | +329.4% | 892 | +197.3% | 0.00% | – |
| Q4 2017 | $17,000 | +30.8% | 300 | -7.1% | 0.00% | – |
| Q2 2016 | $13,000 | – | 323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |